Sitagliptin vs Pantoprazole: side-by-side comparison
Sitagliptin (DPP-4 inhibitor) and Pantoprazole (Proton pump inhibitor) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Sitagliptin | Pantoprazole |
|---|---|---|
| Therapeutic class | DPP-4 inhibitor | Proton pump inhibitor |
| CAS | 486460-32-6 | 102625-70-7 |
| ATC | A10BH01 | A02BC02 |
| Molecular weight | 407.31 g/mol | 383.37 g/mol |
| Brands with this active ingredient | 1 | 1 |
What they share
Sitagliptin and Pantoprazole share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Sitagliptin acts by a different mechanism than Pantoprazole, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Sitagliptin: La sitagliptine inhibe de façon réversible la DPP-4, sérine protéase responsable de la dégradation rapide du glucagon-like peptide 1 (GLP-1) et du polypeptide insulinotrope glucose-dépendant (GIP). Pantoprazole: Le pantoprazole est un promédicament de type benzimidazole substitué, activé dans l'environnement acide de la cellule pariétale gastrique, où il inhibe de façon irréversible l'enzyme H+/K+-ATPase — la pompe à protons res…
Indications compared
Sitagliptin: La sitagliptine est autorisée chez l'adulte atteint de diabète de type 2, seule ou en association à d'autres antidiabétiques, pour améliorer le contrôle glycémique. Pantoprazole: Le pantoprazole est autorisé chez l'adulte et l'enfant dans le traitement du reflux gastro-œsophagien, y compris la cicatrisation de l'œsophagite érosive et son entretien, de l'ulcère gastroduodénal, dans la prévention d…
Safety profile
Sitagliptin: La sitagliptine est généralement bien tolérée. Pantoprazole: Les effets indésirables fréquents comprennent céphalées, troubles digestifs et vertiges.
Questions fréquentes
Is Sitagliptin better than Pantoprazole? ▾
Sitagliptin and Pantoprazole are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Sitagliptin and Pantoprazole be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Sitagliptin
Products with Pantoprazole
Les informations publiées sur ce site sont fournies à titre documentaire et pédagogique. Elles ne remplacent pas l'avis d'un professionnel de santé qualifié.